US Biosimilars Will Continue to Blossom Under Trump, Says Experts
January 6, 2017
Dan Stanton
BioPharma-Reporter
Axinn partner Stacie Ropka was quoted in the BioPharma-Reporter article, "US Biosimilars Will Continue to Blossom Under Trump, Says Experts."
Click here to access the article.